About enVVeno Medical
enVVeno Medical is a company based in Irvine (United States) founded in 1999 by Norman Jaffe.. enVVeno Medical has raised $874 thousand across 6 funding rounds from investors including Perceptive Advisors, L1 Capital and Nantahala Capital Management. The company has 37 employees as of December 31, 2024. enVVeno Medical operates in a competitive market with competitors including Tactile Medical, Intervene, Sky Medical Technology, DeVoro Medical and Micro Medical Solutions, among others.
- Headquarter Irvine, United States
- Employees 37 as on 31 Dec, 2024
- Founders Norman Jaffe
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
$00as on Dec 31, 2024
-
Net Profit
$-21.82 M7.22as on Dec 31, 2024
-
EBITDA
$-23.3 M5.65as on Dec 31, 2024
-
Total Equity Funding
$874 K (USD)
in 6 rounds
-
Latest Funding Round
$28 M (USD), Post-IPO
Oct 06, 2023
-
Investors
Perceptive Advisors
& 4 more
-
Employee Count
37
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of enVVeno Medical
enVVeno Medical is a publicly listed company on the NASDAQ with ticker symbol NVNO in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of enVVeno Medical
enVVeno Medical has successfully raised a total of $874K across 6 strategic funding rounds. The most recent funding activity was a Post-IPO round of $28 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Post-IPO — $28.0M
-
First Round
First Round
(15 Dec 2015)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2023 | Amount | Post-IPO - enVVeno Medical | Valuation |
investors |
|
| Aug, 2020 | Amount | Post-IPO - enVVeno Medical | Valuation |
investors |
|
| Mar, 2020 | Amount | Post-IPO - enVVeno Medical | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in enVVeno Medical
enVVeno Medical has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Perceptive Advisors, L1 Capital and Nantahala Capital Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health-tech companies are targeted for venture capital investments.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Fundamentally-driven firm investing in micro-cap stocks with long and short strategies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by enVVeno Medical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - enVVeno Medical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Envveno Medical Comparisons
Competitors of enVVeno Medical
enVVeno Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tactile Medical, Intervene, Sky Medical Technology, DeVoro Medical and Micro Medical Solutions, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Home therapy devices for lymphedema and venous ulcers are provided.
|
|
| domain | founded_year | HQ Location |
Catheter-based therapy for chronic venous insufficiency is developed.
|
|
| domain | founded_year | HQ Location |
Electro-stimulation devices are manufactured for deep vein thrombosis treatment.
|
|
| domain | founded_year | HQ Location |
Medical devices for treating cardiac diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of a device for CLI and PAD patients to prevent amputation
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Envveno Medical
Frequently Asked Questions about enVVeno Medical
When was enVVeno Medical founded?
enVVeno Medical was founded in 1999 and raised its 1st funding round 16 years after it was founded.
Where is enVVeno Medical located?
enVVeno Medical is headquartered in Irvine, United States. It is registered at Irvine, California, United States.
Who is the current CEO of enVVeno Medical?
Robert Berman is the current CEO of enVVeno Medical.
Is enVVeno Medical a funded company?
enVVeno Medical is a funded company, having raised a total of $874K across 6 funding rounds to date. The company's 1st funding round was a Post-IPO of $650K, raised on Dec 15, 2015.
How many employees does enVVeno Medical have?
As of Dec 31, 2024, the latest employee count at enVVeno Medical is 37.
What does enVVeno Medical do?
Developer of medical device for the the treatment of venous diseases. The company is focused on the development of bioprosthetic solutions VenoValve an implant for the treatment of deep venous chronic venous insufficiency to assist in propelling blood up the leg, and back to the heart and lungs.
Who are the top competitors of enVVeno Medical?
enVVeno Medical's top competitors include Tactile Medical, Intervene and Sky Medical Technology.
Is enVVeno Medical publicly traded?
Yes, enVVeno Medical is publicly traded on NASDAQ under the ticker symbol NVNO.
Who are enVVeno Medical's investors?
enVVeno Medical has 5 investors. Key investors include Perceptive Advisors, L1 Capital, Nantahala Capital Management, Kingdon Capital Management, and Velan Capital.
What is enVVeno Medical's ticker symbol?
The ticker symbol of enVVeno Medical is NVNO on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.